Several authors reported a protective role of adiponectin in ERα-positive breast cancer cells (86, 100, 105, 112–116), but divergent actions of the adipokine are emerging on this specific breast cancer subtype (52–54, 117, 118). This evidence concerns the gene ADIPOQ and breast carcinoma.